Fig. 1From: Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndromeGI symptoms scores in IBS-D patients at different times during the study. Note: *P < 0.05, ** P < 0.01, *** P < 0.001; IBS, irritable bowel syndrome; IBS-D, diarrhea-predominant IBS; GI symptoms, gastrointestinal symptomsBack to article page